1. Home
  2. WLK vs RGC Comparison

WLK vs RGC Comparison

Compare WLK & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westlake Corporation

WLK

Westlake Corporation

HOLD

Current Price

$73.82

Market Cap

10.3B

Sector

Industrials

ML Signal

HOLD

Logo Regencell Bioscience Holdings Limited

RGC

Regencell Bioscience Holdings Limited

HOLD

Current Price

$5.72

Market Cap

11.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLK
RGC
Founded
1986
2014
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Major Chemicals
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
11.5B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
WLK
RGC
Price
$73.82
$5.72
Analyst Decision
Buy
Analyst Count
15
0
Target Price
$106.87
N/A
AVG Volume (30 Days)
1.0M
536.5K
Earning Date
05-05-2026
10-31-2025
Dividend Yield
1.90%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,170,000,000.00
N/A
Revenue This Year
$5.51
N/A
Revenue Next Year
$3.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$56.33
$4.51
52 Week High
$124.23
$69.00

Technical Indicators

Market Signals
Indicator
WLK
RGC
Relative Strength Index (RSI) 33.54 32.41
Support Level $71.96 $4.51
Resistance Level $79.57 $29.26
Average True Range (ATR) 2.19 0.79
MACD 0.47 0.66
Stochastic Oscillator 6.64 36.12

Price Performance

Historical Comparison
WLK
RGC

About WLK Westlake Corporation

Westlake is a forward-integrated commodity chemicals firm based in Houston. It began as a single low-density polyethylene plant and expanded its capabilities to include ethylene, vinyl chloride monomers, and polyvinyl chloride over the next two decades. The acquisition of Axiall in 2016 made it a North American leader in chlor-alkali and PVC. Today, Westlake has two defined segments: performance and essential materials, and housing and infrastructure products. The HIP segment began operating in 2022 following a series of acquisitions in the building products space. The firm aims to maximize the value of its chemical production by integrating with the HIP segment, realizing the higher margins of finished commercial goods.

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Share on Social Networks: